Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Unaudited Financial Results of Cipla Limited (the Company) for the quarter and nine months ended 31st December 2024 Canara Robeco Equity Hybrid Fund (IDCW-M) 112.88 7,80,000 1.08 Canara Robeco Equity ...

Discover how innovation, global access, and quality... Dec 26, 2024 11:20 Cipla Fined Rs 1 Crore by GST Authority for Credit Claim Pharma company Cipla has been fined over Rs 1 crore by the GST ...

The Ebitda margin expanded to 28.1% from 26.5%. Cipla also posted an exceptional loss of Rs 195 crore in the third quarter. Revenue rises 7.1% to Rs 7,073 crore versus Rs 6,604 crore (Bloomberg ...

Cipla's EBITDA for the quarter rose by 15.7 per cent YoY to Rs 1,989 crore, while the EBITDA margin improved by 184 basis points to 28.1 per cent. The company said its sustained margins were a result ...

As per the brokerage firm, Cipla’s Q3FY25 exceeded expectations, mostly driven by a healthier product mix and lower research and development spending. The company reported a 7.1% YoY revenue ...

Q3 financial print Cipla reported a 48.7 per cent year-on-year (Y-o-Y) increase in its consolidated profit after tax (PAT) for Q3FY25, reaching Rs 1,570.5 crore, while revenue from operations grew 7.1 ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

77 percent of Africans are younger than 35. But they are also the least represented demographic. It's time their voices are heard as they shape the future of Africa.